Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine

被引:17
作者
Dimopoulos, MA [1 ]
Theodorakis, M [1 ]
Kostis, E [1 ]
Papadimitris, C [1 ]
Moulopoulos, LA [1 ]
AnastasiouNana, M [1 ]
机构
[1] UNIV ATHENS,SCH MED,ALEXANDRA HOSP,DEPT CLIN THERAPEUT,GR-11527 ATHENS,GREECE
关键词
2; chlorodeoxyadenosine; Langerhans cell histiocytosis; 2-CHLORODEOXYADENOSINE; TOXICITY; THERAPY;
D O I
10.3109/10428199709042509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Langerhans-cell histiocytosis (LCH) is a rare condition with a wide clinical spectrum and variable prognosis. Patients with multisystem LCH have been treated with a variety of agents but may develop resistant and progressive disease. Based on a preliminary encouraging report on the activity of 2 chlorodoxyadenosine in this disease, we administered this agent to a patient with LCH which was resistant to corticosteroids and etoposide. After 4 courses of treatment the patient achieved a complete remission which is currently ongoing for 12 months. 2 CdA appears to be effective in patients with resistant LCH and warrants investigation in previously untreated patients with poor risk disease.
引用
收藏
页码:187 / 189
页数:3
相关论文
共 9 条
[1]   POTENT TOXICITY OF 2-CHLORODEOXYADENOSINE TOWARD HUMAN MONOCYTES INVITRO AND INVIVO - A NOVEL-APPROACH TO IMMUNOSUPPRESSIVE THERAPY [J].
CARRERA, CJ ;
TERAI, C ;
LOTZ, M ;
CURD, JG ;
PIRO, LD ;
BEUTLER, E ;
CARSON, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) :1480-1488
[2]  
CLINE MJ, 1994, BLOOD, V84, P2840
[3]   TREATMENT STRATEGY FOR DISSEMINATED LANGERHANS CELL HISTIOCYTOSIS [J].
GADNER, H ;
HEITGER, A ;
GROIS, N ;
GATTERERMENZ, I ;
LADISCH, S .
MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 23 (02) :72-80
[4]  
KOMP DM, 1991, SEMIN ONCOL, V18, P18
[5]  
MAHMOUD HH, 1991, BLOOD, V77, P721
[6]   2-CHLORODEOXYADENOSINE-INDUCED COMPLETE REMISSIONS IN LANGERHANS-CELL HISTIOCYTOSIS [J].
SAVEN, A ;
FOON, KA ;
PIRO, LD .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) :430-432
[7]   MECHANISM OF DEOXYADENOSINE AND 2-CHLORODEOXYADENOSINE TOXICITY TO NONDIVIDING HUMAN-LYMPHOCYTES [J].
SETO, S ;
CARRERA, CJ ;
KUBOTA, M ;
WASSON, DB ;
CARSON, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (02) :377-383
[8]  
TALLMAN MS, 1995, BLOOD, V86, P2463
[9]   LANGERHANS-CELL HISTIOCYTOSIS (HISTIOCYTOSIS-X) - A CLONAL PROLIFERATIVE DISEASE [J].
WILLMAN, CL ;
BUSQUE, L ;
GRIFFITH, BB ;
FAVARA, BE ;
MCCLAIN, KL ;
DUNCAN, MH ;
GILLILAND, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (03) :154-160